GLP-1 receptor agonist diabetes medications linked to reduced dementia risk

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective glucose-lowering therapies—medications that lower blood sugar and reduce the risk of heart disease in people with diabetes—affect the risk of developing dementia.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup